What is the 13F Pro Quality Score for ACNT?

13F Pro ranks ASCENT INDUSTRIES CO. (ACNT) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ACNT's current score at https://13fpro.ai/research/ACNT (free sign-up required for the full ranking).

Where does 13F Pro source ACNT data?

All ASCENT INDUSTRIES CO. fundamentals and ownership data come directly from SEC EDGAR. ASCENT INDUSTRIES CO. files with the SEC under CIK 95953. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ACNT in?

ASCENT INDUSTRIES CO. (ACNT) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ACNT research updated on 13F Pro?

ACNT's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

ASCENT INDUSTRIES CO.(ACNT)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 95953 ACNT stock profile & AI dashboard →

13F Pro Quality Score

29.5/100

Rank #2,404 of 2,879 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

2.6/100

Profitability

54.0/100

Balance Sheet

35.6/100

Earnings Quality

30.0/100

Free Cash Flow

18.9/100

Institutional Flow

83.4/100

Revenue Scale

14.5/100

Dilution Risk

43.5/100

ACNT Stock Analysis & AI Quality Score

AI stock analysis and institutional research for ASCENT INDUSTRIES CO. (ACNT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ACNT at 29.5/100 on a 32-signal composite quality model, placing it at rank #2,404 of 2,879 stocks — the bottom half of the AI-ranked universe. ACNT scores in the top quartile across institutional flow (83.4). Areas of concern include revenue growth (2.6) and revenue scale (14.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 43.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), ASCENT INDUSTRIES CO. reports quarterly revenue of $19.4M, net income of $-2.0M, an operating margin of -12.2%. Top institutional holders of ACNT by reported 13-F value include Mink Brook Asset Management, BlackRock,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ACNT trades on the Nasdaq exchange and files with the SEC under CIK 95953. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACNT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ASCENT INDUSTRIES CO. directly from SEC EDGAR. ASCENT INDUSTRIES CO.'s 13F Pro composite quality score has ranged between 22 and 56 since 2022, currently 29.5 — a declining long-term trajectory across 23 quarterly and live scoring snapshots.

Revenue

Q1 2026

$19.4M

Net Income

Q1 2026

$-2.0M

Free Cash Flow

Q1 2026

$-5.8M

Operating Margin

Q1 2026

-12.2%

ROIC

Q1 2026

-2.9%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-7.2% YoY

$74.9MFY 2025

FY22 $262.0MFY23 $193.2MFY24 $80.8MFY25 $74.9M

Net Income

+106.4% YoY

$867.0KFY 2025

FY22 $22.1MFY23 $-26.6MFY24 $-13.6MFY25 $867.0K

Operating Income

+34.9% YoY

$-7.0MFY 2025

FY22 $14.5MFY23 $-37.4MFY24 $-10.8MFY25 $-7.0M

EPS (Diluted)

+106.7% YoY

$0.09FY 2025

FY22 $2.12FY23 $-2.63FY24 $-1.35FY25 $0.09

Total Assets

-24.0% YoY

$111.9MFY 2025

FY22 $269.0MFY23 $163.3MFY24 $147.3MFY25 $111.9M

Total Debt

—FY 2025

FY22 $74.0MFY23 $0.00FY24 $0.00FY25 —

Op. Cash Flow

-103.5% YoY

$-519.0KFY 2025

FY22 $5.6MFY23 $23.1MFY24 $14.7MFY25 $-519.0K

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$74.9M -7.2%	$80.8M -58.2%	$193.2M -26.3%	$262.0M -21.7%	$334.7M +30.7%	$256.0M
Net Income	$867.0K +106.4%	$-13.6M +48.9%	$-26.6M -220.7%	$22.1M +9.0%	$20.2M +174.2%	$-27.3M
Operating Income	$-7.0M +34.9%	$-10.8M +71.1%	$-37.4M -357.4%	$14.5M -46.8%	$27.3M +188.0%	$-31.1M
EPS (Diluted)	$0.09 +106.7%	$-1.35 +48.7%	$-2.63 -224.1%	$2.12 -0.9%	$2.14 +171.8%	$-2.98
Total Assets	$111.9M -24.0%	$147.3M -9.8%	$163.3M -39.3%	$269.0M +1.1%	$266.0M +28.5%	$207.0M
Total Debt	—	$0.00	$0.00 -100.0%	$74.0M +1.6%	$72.9M +17.0%	$62.2M
Operating Cash Flow	$-519.0K -103.5%	$14.7M -36.4%	$23.1M +313.8%	$5.6M -70.7%	$19.1M +6.0%	$18.0M

AI Insight: ACNT Ratio Trends

Operating losses deepened to -12.0% margin in TTM 2026 while ROIC deteriorated to -10.2%, indicating persistent operational challenges.

• Operating margin worsened from -2.9% in Q3 2024 to -12.2% in Q1 2026, showing consistent deterioration.

• ROIC declined from 13.7% in Q4 2024 to -11.6% in Q1 2026, signaling capital deployment struggles.

• ROE improved from -26.0% in Q3 2024 to -9.7% in Q1 2026, though remains deeply negative.

⚠ Q2 2025 showed anomalous 53.5% net margin spike amid -31.4% operating margin, suggesting one-time items.

⚠ Operating losses have persisted across all reported quarters with no clear inflection toward profitability.

Get alerted when ACNT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ASCENT INDUSTRIES CO. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ACNT

Mink Brook Asset Management LLC
$11.8M886,769 sh
BlackRock, Inc.
$6.8M510,498 sh
VANGUARD CAPITAL MANAGEMENT LLC
$4.6M345,487 sh
RENAISSANCE TECHNOLOGIES LLC
$4.4M329,000 sh
BARD ASSOCIATES INC
$4.3M325,582 sh
DIMENSIONAL FUND ADVISORS LP
$3.8M283,567 sh
WELLS FARGO & COMPANY/MN
$2.8M208,504 sh
De Lisle Partners LLP
$2.6M197,824 sh
Russell Investments Group, Ltd.
$2.6M196,113 sh
AMERICAN CENTURY COMPANIES INC
$2.3M175,223 sh

Fund	Value	Shares
Mink Brook Asset Management LLC	$11.8M	886,769
BlackRock, Inc.	$6.8M	510,498
VANGUARD CAPITAL MANAGEMENT LLC	$4.6M	345,487
RENAISSANCE TECHNOLOGIES LLC	$4.4M	329,000
BARD ASSOCIATES INC	$4.3M	325,582
DIMENSIONAL FUND ADVISORS LP	$3.8M	283,567
WELLS FARGO & COMPANY/MN	$2.8M	208,504
De Lisle Partners LLP	$2.6M	197,824
Russell Investments Group, Ltd.	$2.6M	196,113
AMERICAN CENTURY COMPANIES INC	$2.3M	175,223

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ACNT on your watchlist

Track score changes the day ASCENT INDUSTRIES CO. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ACNT a good stock to buy?

13F Pro's AI-powered analysis of ASCENT INDUSTRIES CO. (ACNT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACNT are available on the ACNT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ACNT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACNT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ASCENT INDUSTRIES CO.'s investment landscape.